What's Happening?
Peli BioThermal has acquired Evo from BioLife Solutions, enhancing its portfolio of temperature-controlled logistics solutions. The acquisition includes cryogenic shippers and the evoIS technology platform, which are crucial for the growing Cell and Gene Therapy sector.
Why It's Important?
The acquisition of Evo strengthens Peli BioThermal's position in the cold chain logistics market, particularly in the Cell and Gene Therapy sector. This move allows the company to offer a more comprehensive range of solutions, meeting the increasing demand for reliable and precise temperature-controlled transport. The acquisition is expected to drive innovation and expand Peli BioThermal's market reach.
What's Next?
Peli BioThermal will focus on integrating Evo's products into its existing portfolio and leveraging its global resources to enhance service delivery. The company may also explore further acquisitions or partnerships to expand its capabilities and market presence. Industry observers will be watching for the impact of this acquisition on Peli BioThermal's growth and competitive position.
